Acuta Capital Partners’s IRIDEX IRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding IRIX
PAPAIJV
ICM
IP
Acuta Capital Partners's IRIX Position: Q4 2019 in Review
Acuta Capital Partners sold out of IRIDEX (IRIX) in Q4 2019, closing a stake of 1,171,300 shares — an estimated $2.17M sold.
Acuta Capital Partners first reported a position in IRIX in Q4 2014 and held it in 20 quarters. The position peaked at $21.9M in Q4 2016. 26 funds tracked by Wall St. Rank hold IRIX as of Q4 2019.
- Acuta Capital Partners reported no remaining IRIDEX position as of Q4 2019 after selling out during the quarter.
- Acuta Capital Partners sold 1,171,300 IRIDEX shares in Q4 2019, an estimated $2.17M.
- Acuta Capital Partners first reported a position in IRIDEX in Q4 2014 and held it in 20 quarters.
- Acuta Capital Partners's IRIDEX position peaked at $21.9M in Q4 2016.
- 26 funds tracked by Wall St. Rank held IRIDEX as of Q4 2019.
Based on Acuta Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.